(Press-News.org) COVID-19 outbreaks in French nursing homes almost certainly started in staff - and none of measures put in place stopped the virus from taking hold, new research being presented at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), held online this year, shows.
Residents of long-term care facilities represent a small fraction of the general population but account for a disproportionate number of SARS-CoV-2-related deaths in many countries.
In France, 5,203 outbreaks (of 1 case or more) were reported in nursing homes during the first wave of COVID-19. In the Auvergne-Rhône-Alpes region, there were 651 outbreaks, 3,885 residents had confirmed COVID-19 infection and 1,772 (46%) subsequently died.
Little is known, however, about how the COVID-19 virus enters nursing homes nor how it spreads in this complex environment.
Emilie Piet, of the Centre Hospitalier Annecy Geneva, Epagny Metz-Tessy, France and colleagues, carried out a cross-sectional survey in nursing homes in the French Alps from March 1 to May 31 May 2020.
The survey covered cases of COVID-19 among residents and staff during the first lockdown, as well as the staffing during the pandemic, including staffing levels and the use of interim carers.
It also asked about the nursing homes' characteristics (e.g. number of residents, whether these were private or public facilities, if they cared for dementia patients) and hygiene measures implemented (these included wearing face masks, confining residents to their rooms, use of alcohol-based hand sanitiser and bans on visits).
Seventy four (33%) of 225 nursing homes completed the survey. A total of 22 homes, with 1,795 residents in total, had an outbreak of COVID-19 - defined as at least three cases. (See table 1 of abstract).
In the homes with outbreaks, 26% (473/1,795) of the residents had a confirmed or probable case of COVID-19; 19% (341/1,795) of residents were hospitalised and 253 (14%) died of any cause.
In contrast, 0.2% (9/4,096 residents) of residents in the outbreak-free homes had confirmed or probable COVID-19, 6% (247/4,096) were hospitalised and 6% (250/4,096) died of any cause during the period studied.
A total of 19% (250/1,348) of staff in the homes with outbreaks had confirmed or probable cases of COVID-19, compared to 1.4% (46/3,304) in the outbreak-free homes.
The results revealed a strong link between cases in staff and cases in residents.
Further analysis showed that cases of COVID-19 in staff were the only predictor of an outbreak among residents.
In other words, none of the nursing homes' characteristics seemed to have any effect and nor did any of the hygiene measures. However, the homes all employed similar hygiene measures, making it difficult to tease apart their effect, says Dr Piet.
She adds: "This study shows that when strict hygiene measures are implemented in nursing homes, factors such as the number of beds, the ratio of staff to residents and the use of temporary staff do not influence outbreaks.
"We found that apart from staff infections, nothing influenced the occurrence of outbreaks and so, during the national lockdown, staff were the likely source of COVID-19 outbreaks among nursing home residents."
INFORMATION:
The flu vaccine may provide vital protection against COVID-19, new research being presented at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), held online this year, concludes.
An analysis of patient data from around the world strongly suggests that the annual flu shot reduces the risk of stroke, sepsis and DVT in patients with COVID-19. Patients with COVID-19 who had been vaccinated against flu were also less likely to visit the emergency department and be admitted to the intensive care unit (ICU).
Immunising the world against COVID-19 is a daunting challenge and, although production and distribution of vaccines increases daily, some countries are not expected to vaccinate large numbers of their population ...
A vaccine to protect against infection with hepatitis C could be in use within 5 years, says Professor Sir Michael Houghton, who won the Nobel Prize for Medicine and Physiology along with three other scientists for discovering the hepatitis C virus (HCV) in 1989. Sir Michael will discuss the development of a vaccine in a special presentation at this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), held online this year.
Up to 2 million new HCV infections occur every year around the world, with an estimated 70 million carriers of the virus globally, most of whom are not diagnosed. The virus is estimated to cause some 400,000 deaths annually. Many infected with the virus go on to develop liver cirrhosis and liver cancer.
"While the advent of ...
Water-jet nozzles in electric toilets--commonly used in Japan and other parts of Asia--may be reservoirs for multidrug-resistant Pseudomonas aeruginosa (MDRP) in hospitals, increasing the risk of dangerous germ transmission among patients, according to new research being presented at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) held online this year.
"This is the first report of hospital transmissions associated with electric toilets and could have major implications for infection control," says Dr Itaru Nakamura from Tokyo Medical University Hospital ...
New research presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) taking place online (9-12 July) shows that covering high-touch (the most regularly touched) surfaces in hospitals with silver-impregnated foil could significantly reduce levels of contamination by clinically important bacterial pathogens.
The study by Professor Andreas Widmer and colleagues at the University Hospital Basel, Basel, Switzerland, evaluated the antimicrobial effectiveness of a polyvinyl chloride (PVC) foil containing an integrated silver-based agent containing 2% silver ions.
The hospital environment has increasingly been recognised as having critical importance when formulating infection control measures ...
Obese patients with a form of advanced prostate cancer survive longer than overweight and normal weight patients, new research has found.
The study, presented today at the European Association of Urology congress, EAU21, followed more than 1500 patients over three years. Patients classed as obese - with a BMI over 30 - had a ten percent higher survival rate than thinner patients over 36 months.
Although obesity is usually associated with an increased risk of death from many cancers and some other chronic diseases, there is some evidence in a few cancers of a survival advantage for patients with high body mass index. ...
Being immersed in a stunning 'virtual' Icelandic landscape can reduce the pain caused by uncomfortable medical procedures, new research has found.
The study compared patients with and without virtual reality (VR) headsets having rigid cystoscopies, where a rigid telescope is inserted through the urethra into the bladder. The research is being presented today at the European Association of Urology congress, EAU21.
Diagnosing and treating bladder cancer usually requires checking the bladder through a cystoscopy, which is perceived by patients as unpleasant and painful. Some patients avoid follow-up and as a result suffer uncontrolled and irreversible development of the disease. It is possible to have a flexible cystoscopy, which is less painful, ...
A new class of drug successfully targets treatment-resistant prostate cancers and prolongs the life of patients. The treatment delivers beta radiation directly to tumour cells, is well tolerated by patients and keeps them alive for longer than standard care, found a phase 3 trial to be presented at the European Association of Urology congress, EAU21, today.
Despite progress in medicine in recent years, metastatic castration-resistant prostate cancer remains untreatable and fatal. The new treatment, known as Lu-PSMA-617, takes a new approach, targeting a molecule called PSMA, which is known to be increased on the surfaces of the tumour cells, destroying them and their surrounding microenvironment.
Professor Johann de Bono, Professor of Experimental Cancer Medicine at The ...
Using an existing drug for late-stage kidney cancer at an earlier stage of the disease could reduce the risk of cancer recurring by a third, according to new research.
The findings from the Phase III trial are presented today at the European Association of Urology congress (EAU21).
There is a high risk of kidney cancer returning, following surgery to remove tumours, but there is currently no treatment to help prevent this.
The KEYNOTE study involved just under 1000 patients with kidney cancer who had undergone surgery. Half of them were given the immunotherapy drug pembrolizumab, or pembro, and the other half a placebo.
Pembro is used to treat a number of cancers, including late-stage kidney cancer, where the disease has spread to ...
Researchers in Belgium report on the case of a 90-year-old woman who was simultaneously infected with two different variants of concern (VOCs) of COVID-19, in a Case Report being presented at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) held online this year.
On March 3 2021, the woman, whose medical history was unremarkable, was admitted to the OLV Hospital in the Belgian city of Aalst after a spate of falls. She tested positive for COVID-19 on the same day. She lived alone and received nursing care at home, and had not been vaccinated against COVID-19.
Initially, there were no ...
New research being presented at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), held online this year, reveals raw dog food to be a major source of antibiotic-resistant bacteria, making it an international public health risk.
With some of the multidrug-resistant bacteria in raw dog food identical to those found in hospital patients in several different European countries, the researchers say the trend for feeding dogs raw food may be fuelling the spread of antibiotic resistant-bacteria.
Drug-resistant infections kill an estimated 700,000 people a year globally and, with the figure projected to rise to 10 million ...
